SELICK HAROLD E
Insider CIK 1287233 · CBIO Director · THLD Chief Executive Officer, Director · PTGX Director · PDLI Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-03-26 | 2026-03-27 | 24,000 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-03-26 | 2026-03-27 | 24,000 | $12.88 | $309.1K | 84,845 | SEC↗ |
| PTGX Protagonist Therapeutics, | S Sale | 2026-03-26 | 2026-03-27 | 24,000 | $105.00 | $2.52M | 60,845 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2026-01-09 | 2026-01-13 | 14,299 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2026-01-09 | 2026-01-13 | 14,299 | $4.21 | $60.2K | 60,845 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2026-01-02 | 2026-01-06 | 3,762 | — | $0 | 3,762 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2026-01-02 | 2026-01-06 | 2,695 | — | $0 | 46,546 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2025-04-28 | 2025-04-30 | 10,725 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2025-04-28 | 2025-04-30 | 10,725 | $1.16 | $12.4K | 43,851 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2025-01-02 | 2025-01-06 | 6,584 | — | $0 | 6,584 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award | 2025-01-02 | 2025-01-06 | 5,130 | — | $0 | 33,126 | SEC↗ |
| MTEM Molecular Templates, Inc. | A Award deriv | 2024-09-27 | 2024-09-30 | 1,000 | — | $0 | 1,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2024-03-07 | 2024-03-11 | 6,490 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2024-03-07 | 2024-03-11 | 6,490 | $1.89 | $12.3K | 27,996 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2024-01-02 | 2024-01-04 | 25,700 | — | $0 | 25,700 | SEC↗ |
| MTEM Molecular Templates, Inc. | A Award deriv | 2023-10-27 | 2023-10-31 | 1,000 | — | $0 | 1,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2023-04-10 | 2023-04-11 | 6,196 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2023-04-10 | 2023-04-11 | 6,196 | $0.87 | $5.4K | 21,506 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2023-01-16 | 2023-01-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MTEM Molecular Templates, Inc. | A Award deriv | 2022-06-03 | 2022-06-06 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2022-05-26 | 2022-05-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| MTEM Molecular Templates, Inc. | A Award deriv | 2021-06-03 | 2021-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2021-05-27 | 2021-05-28 | 18,000 | — | $0 | 18,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2020-05-28 | 2020-05-29 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MTEM Molecular Templates, Inc. | A Award deriv | 2020-05-28 | 2020-06-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | P Buy | 2020-03-12 | 2020-03-12 | 12,000 | $6.70 | $80.4K | 15,310 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award deriv | 2019-06-20 | 2019-06-24 | 126,050 | $3.00 | $378.1K | 126,050 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2019-06-07 | 2019-06-11 | 12,000 | — | $0 | 12,000 | SEC↗ |
| MTEM Molecular Templates, Inc. | A Award deriv | 2019-05-29 | 2019-05-30 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise deriv | 2019-04-01 | 2019-04-02 | 3,310 | — | $0 | 0 | SEC↗ |
| PTGX Protagonist Therapeutics, | M Exercise | 2019-04-01 | 2019-04-02 | 3,310 | $1.31 | $4.3K | 3,310 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2018-06-08 | 2018-06-12 | 54,348 | $2.76 | $150.0K | 256,828 | SEC↗ |
| MTEM Molecular Templates, Inc. | A Award deriv | 2018-05-31 | 2018-06-04 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2018-05-29 | 2018-06-12 | 12,000 | — | $0 | 12,000 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | A Award deriv | 2018-01-16 | 2018-01-18 | 197 | — | $0 | 197 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | D To issuer deriv | 2018-01-16 | 2018-01-18 | 197 | — | $0 | 0 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | D To issuer deriv | 2018-01-16 | 2018-01-18 | 550 | — | $0 | 0 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | A Award deriv | 2018-01-16 | 2018-01-18 | 550 | — | $0 | 550 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | D To issuer deriv | 2018-01-16 | 2018-01-18 | 450 | — | $0 | 0 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | A Award deriv | 2018-01-16 | 2018-01-18 | 450 | — | $0 | 450 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | D To issuer deriv | 2018-01-16 | 2018-01-18 | 500 | — | $0 | 0 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | A Award deriv | 2018-01-16 | 2018-01-18 | 500 | — | $0 | 500 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | D To issuer deriv | 2018-01-16 | 2018-01-18 | 10,000 | — | $0 | 0 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | A Award deriv | 2018-01-16 | 2018-01-18 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MTEM Molecular Templates, Inc. | A Award deriv | 2017-10-09 | 2017-10-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | A Award deriv | 2017-07-13 | 2017-07-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2017-06-09 | 2017-06-12 | 60,729 | $2.47 | $150.0K | 202,480 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2017-05-25 | 2017-05-26 | 12,000 | — | $0 | 12,000 | SEC↗ |
| PTGX Protagonist Therapeutics, | A Award deriv | 2016-09-13 | 2016-09-15 | 24,000 | — | $0 | 24,000 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | A Award deriv | 2016-06-09 | 2016-06-13 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2016-06-02 | 2016-06-03 | 71,023 | $3.52 | $250.0K | 141,751 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | A Award deriv | 2016-03-14 | 2016-03-15 | 800,000 | — | $0 | 800,000 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | A Award deriv | 2015-10-22 | 2015-10-26 | 6,750 | — | $0 | 6,750 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | A Award deriv | 2015-10-22 | 2015-10-26 | 8,250 | — | $0 | 8,250 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | A Award deriv | 2015-10-22 | 2015-12-15 | 6,750 | — | $0 | 6,750 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | J Other deriv | 2015-08-20 | 2015-08-20 | 2,966 | — | $0 | 2,966 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | J Other deriv | 2015-08-20 | 2015-08-20 | 287 | — | $0 | 287 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | J Other | 2015-08-20 | 2015-08-20 | 382 | — | $0 | 16,614 | SEC↗ |
| CBIO CATALYST BIOSCIENCES, INC. | J Other | 2015-08-20 | 2015-08-20 | 16,232 | — | $0 | 16,232 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2015-05-28 | 2015-05-29 | 22,059 | $6.80 | $150.0K | 70,728 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | A Award deriv | 2015-02-26 | 2015-03-02 | 400,000 | — | $0 | 400,000 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2014-11-26 | 2014-11-28 | 2,110 | $8.08 | $17.0K | 48,369 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2014-11-26 | 2014-11-28 | 300 | $8.08 | $2.4K | 48,669 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2014-11-26 | 2014-11-28 | 100 | $8.08 | $808 | 46,259 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2014-11-26 | 2014-11-28 | 100 | $8.08 | $808 | 44,159 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2014-11-26 | 2014-11-28 | 1,390 | $8.09 | $11.2K | 44,059 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | P Buy | 2014-11-26 | 2014-11-28 | 2,000 | $8.08 | $16.2K | 46,159 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | X Exercise deriv | 2014-10-02 | 2014-10-03 | 20,942 | — | $0 | 20,942 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | X Exercise | 2014-10-02 | 2014-10-03 | 20,942 | $2.05 | $42.9K | 433,870 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2014-05-28 | 2014-05-30 | 5,371 | $9.31 | $50.0K | 42,669 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | A Award deriv | 2014-05-16 | 2014-05-19 | 325,000 | — | $0 | 325,000 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | X Exercise deriv | 2013-06-17 | 2013-06-18 | 19,607 | — | $0 | 0 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | X Exercise | 2013-06-17 | 2013-06-18 | 19,607 | $1.86 | $36.5K | 403,928 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2013-05-21 | 2013-05-21 | 5,974 | $8.37 | $50.0K | 37,298 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | A Award deriv | 2013-03-13 | 2013-03-25 | 360,000 | — | $0 | 360,000 | SEC↗ |
| PDLI PDL BIOPHARMA, INC. | A Award | 2012-06-05 | 2012-06-06 | 7,924 | $6.31 | $50.0K | 31,324 | SEC↗ |
| THLD THRESHOLD PHARMACEUTICALS | A Award deriv | 2012-04-06 | 2012-04-10 | 325,000 | — | $0 | 325,000 | SEC↗ |